Innovagen

Executive Summary

Innovagen, founded in 1995 and headquartered in Lund, Sweden, is a specialized provider of antibody development and engineering services. The company offers end-to-end solutions including antigen generation, antibody development, and modifications, serving as a reliable research partner for life science organizations. With over 25 years of experience, Innovagen has built a strong reputation for tailored, high-quality services in the competitive antibody market. While privately held with no disclosed funding or valuation, its longevity suggests operational stability and a loyal customer base. The company operates in a growing segment driven by increasing demand for custom antibodies in research, diagnostics, and therapeutics.

Upcoming Catalysts (preview)

• Q3 2026Expansion of antibody engineering capabilities through novel platform launch70% success
• Q2 2026Strategic partnership with a mid-size pharmaceutical company50% success